Medicare Enrolled
Dr. Terence Favazza, M.D.
Urology Physician · Live Oak, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Favazza from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Favazza?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Favazza
Dr. Terence Favazza is an urology physician in Live Oak, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Favazza performed 5,896 Medicare services across 3,434 unique beneficiaries.
Between the years covered by Open Payments, Dr. Favazza received a total of $10,121 from 39 pharmaceutical and/or device companies across 215 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Favazza is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 19% volume in TX
$10,121 industry payments
Medicare Practice Summary
Medicare Utilization ↗5,896
Medicare services
Top 19% in TX for urology physician
3,434
Unique beneficiaries
$44
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~295 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Infectious disease DNA/RNA test A laboratory test that uses a specific technique to detect the genetic material of an organism. This method amplifies the target DNA or RNA to identify the presence of the organism. |
1,400 | $34 | $78 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
673 | $40 | $79 |
| Urinalysis with microscopic exam A urine test performed manually that includes examining the sample under a microscope to check for abnormalities. |
583 | $3 | $15 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
555 | $86 | $215 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
521 | $59 | $150 |
| PSA test (prostate cancer screening) | 297 | $18 | $110 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
268 | $8 | $10 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
180 | $114 | $313 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
169 | $7 | $95 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
125 | $175 | $490 |
| Yeast/candida DNA test A laboratory test that uses an amplified probe technique to detect the presence of Candida species, a type of yeast, in a patient sample. |
117 | $34 | $78 |
| Staphylococcus aureus DNA test A laboratory test that uses DNA amplification to detect the presence of Staphylococcus aureus bacteria in a sample. |
117 | $34 | $78 |
| Group B Strep DNA test A laboratory test that uses DNA amplification to detect the presence of Group B Streptococcus bacteria. |
117 | $34 | $78 |
| Total testosterone level test A blood test that measures the total amount of testosterone in your body. This hormone is important for various bodily functions in both men and women. |
95 | $25 | $150 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
64 | $9 | $30 |
| Lower leg neurostimulator electrode insertion A procedure to place an electrode in the lower leg for neurostimulation therapy. |
63 | $88 | $275 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
51 | $43 | $180 |
| Additional urethral implant in prostate Placement of an additional implant into the urethra within the prostate gland using an endoscope. |
51 | $38 | $549 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
51 | $38 | $90 |
| Red blood cell concentration measurement A laboratory test that measures the concentration of red blood cells in the blood. |
49 | $2 | $8 |
| Hemoglobin blood test A blood test that measures the amount of hemoglobin, the protein in red blood cells that carries oxygen. |
49 | $2 | $8 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
47 | $97 | $275 |
| Basic metabolic blood panel A blood test that measures a group of basic chemicals, including total calcium levels. |
44 | $8 | $45 |
| Complete ultrasound of retroperitoneum An ultrasound examination of the structures located behind the abdominal cavity. |
43 | $77 | $345 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
42 | $73 | $210 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
21 | $8 | $25 |
| Urethral implant insertion in prostate A single implant is placed into the urethra within the prostate gland using an endoscope. |
16 | $158 | $923 |
| Bladder irrigation and/or instillation This procedure involves flushing the bladder with fluid to clear it or introducing medication directly into the bladder. |
14 | $58 | $215 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
14 | $36 | $87 |
| Prostate needle biopsy pathology exam Laboratory examination of prostate tissue samples obtained via needle biopsy. The pathologist inspects the tissue both visually and under a microscope to identify any abnormalities. |
14 | $112 | $701 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
13 | $88 | $1,292 |
| Transurethral prostate removal with electrocautery This procedure involves removing the prostate gland through the urethra using an endoscope and an electrocautery knife to control bleeding. |
11 | $535 | $2,600 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
11 | $72 | $350 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
11 | $20 | $285 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.2% high complexity
5.3% medium
94.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$10,121
Total received (2018-2024)
Avg $1,446/year across 7 years
Top 20% in TX for urology physician
39
Companies
215
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,450 (83.5%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,165 (11.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$505 (5.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,196
2023
$1,689
2022
$1,920
2021
$333
2020
$500
2019
$1,878
2018
$2,605
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
NeoTract Inc.
$1,629
Teleflex LLC
$1,169
Astellas Pharma US Inc
$806
Coloplast Corp
$729
PFIZER INC.
$710
Janssen Biotech, Inc.
$701
C. R. Bard, Inc. & Subsidiaries
$625
Medtronic, Inc.
$540
Sumitomo Pharma America, Inc.
$345
Endo Pharmaceuticals Inc.
$296
Boston Scientific Corporation
$268
ABBVIE INC.
$227
Axonics, Inc.
$222
Bayer HealthCare Pharmaceuticals Inc.
$208
Dendreon Pharmaceuticals LLC
$183
Antares Pharma, Inc.
$157
Calyxo, Inc.
$142
UROGEN PHARMA, INC.
$133
AbbVie, Inc.
$133
Augmenix, Inc.
$131
Pacira Pharmaceuticals Incorporated
$122
Amgen Inc.
$103
Chiesi USA, Inc.
$96
Merck Sharp & Dohme Corporation
$44
Blue Earth Diagnostics Limited
$40
180 Medical, Inc.
$39
TOLMAR Pharmaceuticals, Inc.
$37
UROVANT SCIENCES INC
$37
Myovant Sciences Inc.
$36
Tolmar, Inc.
$36
Allergan Inc.
$30
Myriad Genetic Laboratories, Inc.
$27
IMMUNITYBIO, INC.
$25
PROCEPT BioRobotics Corporation
$23
Supernus Pharmaceuticals, Inc.
$19
Ferring Pharmaceuticals Inc.
$16
BOSTON SCIENTIFIC CORPORATION
$15
Axonics Modulation Technologies, Inc.
$12
MEDIVATION FIELD SOLUTIONS LLC
$10
Top 3 companies account for 35.6% of total payments
Associated products mentioned in payments ›
ADVANTAGE FIT · ALTIS · ANKTIVA · AQUABEAM ROBOTIC SYSTEM · Axonics · Axonics r-SNM System · Axumin · BOTOX · CLEVIPREX · CVAC ASPIRATION SYSTEM · ELIGARD · ENDO CLIP III · ERLEADA · Erleada · Exparel · GEMTESA · GENERAL - BPH · GENERAL KIDNEY STONE DISEASE · GENERAL MALE SUI · JELMYTO · KEYTRUDA · Lupron · Lupron Depot · MYRBETRIQ · Myrbetriq · NOCDURNA · ORGOVYX · POLYFORM · POSLUMA · PROLARIS · PROVENGE · Prolia · Rezum Generator · SOLYX · SPEEDICATH · SpaceOAR · TLANDO · TOVIAZ · UROLIFT · UroLift · UroLift System · VIAGRA · XGEVA · XIAFLEX · XTANDI · XYOSTED · Xofigo · Xtandi · rezum Generator
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (84%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $172 per 100 Medicare services performed
Geographic Context
Urology physicians within 10 mi
103
Per 100K population
5.1
County median income
$70,571
Nearest hospital
LAUREL RIDGE TREATMENT CENTER
5.9 mi
5.9 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Favazza is a clinical cardiology specialist, with above-average Medicare volume (top 19% in TX), with low-engagement industry engagement in the top 20% of TX peers, with 20 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Favazza experienced with infectious disease dna/rna test?
Based on Medicare claims data, Dr. Favazza performed 1,400 infectious disease dna/rna test services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Favazza receive payments from pharmaceutical companies?
Yes. Dr. Favazza received a total of $10,121 from 39 companies across 215 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Favazza's costs compare to other urology physicians in Live Oak?
Dr. Favazza's average Medicare payment per service is $44. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Favazza) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Live Oak
Browse urology physicians in Live Oak ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in TX
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in TX
Which TX urology physicians receive the most from drug and device companies.
By company
NeoTract Inc. Payments to Doctors
See all physicians who received payments from NeoTract Inc.
By company
Teleflex LLC Payments to Doctors
See all physicians who received payments from Teleflex LLC.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology